Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD

ClinicalTrials.gov ID: NCT02612428

Public ClinicalTrials.gov record NCT02612428. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 3:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects With Alcohol-Induced Liver Decompensation (AILD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study is to evaluate safety and efficacy of ELAD with respect to overall survival of subjects with a clinical diagnosis of alcohol-induced liver decompensation (AILD) through at least Study Day 91. The secondary objective is to evaluate the proportion of survivors at Study Day 91 using a chi-squared test.

Study identification

NCT ID
NCT02612428
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vital Therapies, Inc.
Industry
Enrollment
151 participants

Conditions and interventions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 49 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2016 (Actual)
Primary completion
Mar 2018 (Actual)
Completion
Sep 2018 (Actual)
Last update posted
Jan 25, 2019

2016 – 2018

United States locations

U.S. sites
21
U.S. states
16
U.S. cities
19
Facility City State ZIP Site status
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
Sharp Coronado Hospital Coronado California 92118 —
Stanford University Medical Center Palo Alto California 94304 —
Schiff Center for Liver Diseases/University of Miami Miami Florida 33136 —
Piedmont Atlanta Hospital Atlanta Georgia 30309 —
Emory University Hospital Atlanta Georgia 30322 —
Rush University Medical Center Chicago Illinois 60612 —
Mercy Medical Center Baltimore Maryland 21202 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
University of Minnesota Minneapolis Minnesota 55455 —
University of Missouri Hospital Columbia Missouri 65212 —
Rutgers University Hospital Newark New Jersey 07101 —
Montefiore Medical Center The Bronx New York 10467 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
The Pennsylvania State University and The Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
Drexel University Philadelphia Pennsylvania 19102 —
Albert Einstein Medical Center Philadelphia Pennsylvania 19141 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15261 —
Houston Methodist Hospital Houston Texas 77030 —
University of Virginia Health System Charlottesville Virginia 22908 —
Aurora St. Luke's Medical Center Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02612428, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 25, 2019 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02612428 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →